JP2005120106A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005120106A5 JP2005120106A5 JP2004363734A JP2004363734A JP2005120106A5 JP 2005120106 A5 JP2005120106 A5 JP 2005120106A5 JP 2004363734 A JP2004363734 A JP 2004363734A JP 2004363734 A JP2004363734 A JP 2004363734A JP 2005120106 A5 JP2005120106 A5 JP 2005120106A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- antigenic
- host cell
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920001184 polypeptide Polymers 0.000 claims 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 230000000890 antigenic effect Effects 0.000 claims 3
- 125000000539 amino acid group Chemical group 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 claims 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Claims (10)
- 配列番号６の少なくとも２０の連続するアミノ酸残基を含む抗原性ポリペプチド。
- 前記ポリペプチドが配列番号６の少なくとも３０の連続するアミノ酸残基を含む、請求項１に記載の抗原性ポリペプチド。
- 配列番号６の配列を含む抗原性ポリペプチド。
- 純粋または組み換えの配列番号６のポリペプチド。
- 請求項１〜４のいずれか１項に記載のポリペプチドを含む融合タンパク質。
- 請求項１〜４のいずれか１項に記載のポリペプチドに特異的に結合する抗体または抗体フラグメント。
- 請求項１〜４のいずれか１項に記載のポリペプチドをコードする核酸。
- 請求項７に記載の核酸を含む発現ベクター。
- 請求項８に記載のベクターを含む宿主細胞。
- 請求項９に記載の宿主細胞を、前記ポリペプチドが発現される条件下で培養する工程を包含する、ポリペプチドを組み換え生産するためのプロセス。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4429397P | 1997-05-07 | 1997-05-07 | |
| US7221298P | 1998-01-22 | 1998-01-22 | |
| US7694798P | 1998-03-05 | 1998-03-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54829998A Division JP2002514083A (ja) | 1997-05-07 | 1998-05-07 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005120106A JP2005120106A (ja) | 2005-05-12 |
| JP2005120106A5 true JP2005120106A5 (ja) | 2005-09-02 |
Family
ID=27366459
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54829998A Withdrawn JP2002514083A (ja) | 1997-05-07 | 1998-05-07 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
| JP2004363734A Withdrawn JP2005120106A (ja) | 1997-05-07 | 2004-12-15 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
| JP2005307907A Pending JP2006052232A (ja) | 1997-05-07 | 2005-10-21 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
| JP2008326610A Withdrawn JP2009089713A (ja) | 1997-05-07 | 2008-12-22 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54829998A Withdrawn JP2002514083A (ja) | 1997-05-07 | 1998-05-07 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005307907A Pending JP2006052232A (ja) | 1997-05-07 | 2005-10-21 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
| JP2008326610A Withdrawn JP2009089713A (ja) | 1997-05-07 | 2008-12-22 | ヒトＴｏｌｌ様レセプタータンパク質、関連する試薬および方法 |
Country Status (20)
| Country | Link |
|---|---|
| EP (4) | EP1798288B1 (ja) |
| JP (4) | JP2002514083A (ja) |
| KR (1) | KR100388860B1 (ja) |
| CN (4) | CN101486759A (ja) |
| AT (3) | ATE348157T1 (ja) |
| AU (1) | AU740333B2 (ja) |
| CA (1) | CA2289912C (ja) |
| CY (1) | CY1109645T1 (ja) |
| DE (3) | DE69841514D1 (ja) |
| DK (2) | DK0980429T3 (ja) |
| ES (3) | ES2279572T3 (ja) |
| HK (3) | HK1022175A1 (ja) |
| ID (1) | ID28299A (ja) |
| IL (1) | IL132614A0 (ja) |
| NO (1) | NO995458L (ja) |
| NZ (1) | NZ338073A (ja) |
| PL (1) | PL336635A1 (ja) |
| PT (1) | PT1798288E (ja) |
| SK (1) | SK146599A3 (ja) |
| WO (1) | WO1998050547A2 (ja) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
| US8212004B2 (en) | 1999-03-02 | 2012-07-03 | Human Genome Sciences, Inc. | Neutrokine-alpha fusion proteins |
| US7696327B1 (en) | 1997-10-17 | 2010-04-13 | Genentech, Inc. | Antibodies to human Toll homologues |
| US20030032090A1 (en) | 1997-05-07 | 2003-02-13 | Schering Corporation, A New Jersey Corporation | Human receptor proteins; related reagents and methods |
| AU2003203679B2 (en) * | 1997-10-17 | 2007-04-05 | Genentech, Inc. | Human toll homologues |
| DK1887014T3 (da) * | 1997-10-17 | 2010-08-02 | Genentech Inc | Humane Toll-homologer |
| JP2000128900A (ja) * | 1998-10-26 | 2000-05-09 | Japan Science & Technology Corp | 新規トル様（Ｔｏｌｌ−ｌｉｋｅ）レセプター及びその遺伝子 |
| US6303321B1 (en) | 1999-02-11 | 2001-10-16 | North Shore-Long Island Jewish Research Institute | Methods for diagnosing sepsis |
| US6740487B1 (en) * | 1999-06-10 | 2004-05-25 | University Of Iowa Research Foundation | Variant TLR4 nucleic acid and uses thereof |
| EP1226251B1 (en) * | 1999-11-02 | 2009-01-21 | Novartis Vaccines and Diagnostics, Inc. | CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| GB9927332D0 (en) * | 1999-11-18 | 2000-01-12 | Leiv Eiriksson Nyfotek As | Novel antibody and uses thereof |
| GB0001704D0 (en) * | 2000-01-25 | 2000-03-15 | Glaxo Group Ltd | Protein |
| US20030083244A1 (en) * | 2000-04-26 | 2003-05-01 | Vernet Corine A.M. | Novel proteins and nucleic acids encoding same |
| MXPA02011618A (es) * | 2000-05-25 | 2003-03-10 | Schering Corp | Proteinas de receptor de humano, reactivos y metodos relacionados. |
| US7879328B2 (en) | 2000-06-16 | 2011-02-01 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to B lymphocyte stimulator |
| NZ522700A (en) | 2000-06-16 | 2006-02-24 | Human Genome Sciences Inc | Antibodies that immunospecifically bind to blys |
| JP2002034565A (ja) * | 2000-07-19 | 2002-02-05 | Japan Science & Technology Corp | 細菌ｄｎａを特異的に認識する受容体タンパク質 |
| WO2002016411A2 (en) * | 2000-08-18 | 2002-02-28 | Human Genome Sciences, Inc. | Binding polypeptides and methods based thereon |
| DE60140773D1 (de) | 2000-08-18 | 2010-01-21 | Dyax Corp | Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS) |
| WO2002022809A2 (en) | 2000-09-15 | 2002-03-21 | Coley Pharmaceutical Gmbh | PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| US7220723B2 (en) | 2001-05-15 | 2007-05-22 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| US7304034B2 (en) | 2001-05-15 | 2007-12-04 | The Feinstein Institute For Medical Research | Use of HMGB fragments as anti-inflammatory agents |
| WO2003031573A2 (en) * | 2001-10-05 | 2003-04-17 | Coley Pharmaceutical Gmbh | Toll-like receptor 3 signaling agonists and antagonists |
| EP1719511B1 (en) * | 2001-11-16 | 2008-12-10 | 3M Innovative Properties Company | N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof |
| GB0127618D0 (en) * | 2001-11-17 | 2002-01-09 | Univ Nottingham | "Composition and method for treatment of wounds" |
| JP2004016021A (ja) | 2002-06-12 | 2004-01-22 | Japan Science & Technology Corp | 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット |
| WO2004053452A2 (en) * | 2002-12-11 | 2004-06-24 | 3M Innovative Properties Company | Assays relating to toll-like receptor activity |
| WO2004094671A2 (en) * | 2003-04-22 | 2004-11-04 | Coley Pharmaceutical Gmbh | Methods and products for identification and assessment of tlr ligands |
| US7696169B2 (en) | 2003-06-06 | 2010-04-13 | The Feinstein Institute For Medical Research | Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| CN1878793A (zh) | 2003-09-11 | 2006-12-13 | 鉴定医疗有限公司 | 拮抗hmgb1的单克隆抗体 |
| CA2540541C (en) | 2003-10-03 | 2012-03-27 | 3M Innovative Properties Company | Alkoxy substituted imidazoquinolines |
| TW200516153A (en) * | 2003-10-03 | 2005-05-16 | Hitachi Chemical Co Ltd | Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same |
| TW200514850A (en) * | 2003-10-03 | 2005-05-01 | Hitachi Chemical Co Ltd | Method of evaluating risk for viral infection |
| EP1697389A4 (en) | 2003-10-24 | 2008-12-24 | Eisai R&D Man Co Ltd | COMPOUNDS AND METHODS FOR TREATING ILLNESS AND SUFFERING TOLL-LIKE RECEPTOR 2 RELATED DISORDERS |
| JP4891088B2 (ja) | 2003-11-25 | 2012-03-07 | スリーエム イノベイティブ プロパティズ カンパニー | 置換されたイミダゾ環系および方法 |
| JP2008022701A (ja) * | 2004-09-24 | 2008-02-07 | Japan Science & Technology Agency | 可溶型Ｔｏｌｌ様受容体４タンパク質 |
| WO2006054129A1 (en) | 2004-11-19 | 2006-05-26 | Institut Gustave Roussy | Improved treatment of cancer by double-stranded rna |
| AR051836A1 (es) | 2004-11-30 | 2007-02-14 | Centocor Inc | Antagonistas de receptor 3 simil toll metodos y usos |
| EP1844201B1 (en) | 2005-02-04 | 2016-08-24 | 3M Innovative Properties Company | Aqueous gel formulations containing immune response modifiers |
| US7498409B2 (en) | 2005-03-24 | 2009-03-03 | Schering Corporation | Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists |
| US7700728B2 (en) | 2005-03-24 | 2010-04-20 | Schering Corporation | Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors |
| US9168286B2 (en) | 2005-10-13 | 2015-10-27 | Human Genome Sciences, Inc. | Methods and compositions for use in treatment of patients with autoantibody positive disease |
| ES2435775T3 (es) | 2005-10-27 | 2013-12-23 | Janssen Biotech, Inc. | Moduladores de receptor tipo Toll 3, procedimientos y usos |
| EP1991264B1 (en) | 2006-03-07 | 2015-01-07 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| WO2007123765A2 (en) | 2006-03-31 | 2007-11-01 | Human Genome Sciences Inc. | Neutrokine-alpha and neutrokine-alpha splice variant |
| CN101134046B (zh) * | 2006-09-01 | 2011-10-05 | 中国医学科学院药物研究所 | Tlr4和tlr9激动剂复方在抑制肿瘤转移中的应用 |
| WO2008147956A2 (en) * | 2007-05-25 | 2008-12-04 | Centocor, Inc. | Toll-like receptor 3 modulators and uses thereof |
| WO2009130616A2 (en) | 2008-04-25 | 2009-10-29 | Innate Pharma | Improved tlr3 agonist compositions |
| EP2116602A1 (en) | 2008-05-07 | 2009-11-11 | Institut Gustave Roussy | Combination products for treating cancer |
| DK2334703T3 (en) | 2008-09-17 | 2015-10-05 | Innate Pharma | Configurations and methods for detection of tlr3 |
| US9512196B2 (en) | 2008-09-22 | 2016-12-06 | Cedars-Sinai Medical Center | Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling |
| EP2328911A4 (en) | 2008-09-22 | 2012-03-14 | Cedars Sinai Medical Center | HUMAN MD-2 IN SHORT FORM AS NEGATIVE REGULATOR OF TOLL-4 TYPE RECEIVER SIGNALING |
| DK2451844T3 (en) | 2009-07-10 | 2015-07-27 | Innate Pharma | Tlr3-retention agents |
| WO2011021524A1 (ja) * | 2009-08-19 | 2011-02-24 | 国立大学法人名古屋大学 | 乳酸菌の付着性を誘導するペプチド及びその用途 |
| WO2013054329A1 (en) * | 2011-10-10 | 2013-04-18 | Yeda Research And Development Co. Ltd. | Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response |
| US9890202B2 (en) | 2010-07-19 | 2018-02-13 | Yeda Research And Development Co. Ltd. | Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases |
| WO2012088272A1 (en) | 2010-12-21 | 2012-06-28 | Duke University | Methods and compositions combining immunotherapy with monocyte activation |
| WO2012095432A2 (en) | 2011-01-12 | 2012-07-19 | Innate Pharma | Tlr3 binding agents |
| JP6093759B2 (ja) | 2011-06-01 | 2017-03-08 | ジャナス バイオセラピューティクス，インク． | 新規の免疫系調節剤 |
| WO2012167053A1 (en) | 2011-06-01 | 2012-12-06 | Janus Biotherapeutics, Inc. | Novel immune system modulators |
| WO2013052550A2 (en) | 2011-10-04 | 2013-04-11 | Janus Biotherapeutics, Inc. | Novel imidazole quinoline-based immune system modulators |
| MX361773B (es) | 2012-05-31 | 2018-12-17 | Innate Pharma | Agentes de ligación a tlr3. |
| US10017739B2 (en) | 2012-09-06 | 2018-07-10 | Duke University | Methods of expanding and assessing B cells and using expanded B cells to treat disease |
| CN113502299B (zh) * | 2021-07-20 | 2023-03-14 | 中国农业大学 | 一种抗金黄色葡萄球菌遗传修饰山羊生产方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2046920B1 (ja) | 1969-06-19 | 1974-05-03 | Citizen Watch Co Ltd | |
| US3940475A (en) | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4859609A (en) | 1986-04-30 | 1989-08-22 | Genentech, Inc. | Novel receptors for efficient determination of ligands and their antagonists or agonists |
| US5789192A (en) | 1992-12-10 | 1998-08-04 | Schering Corporation | Mammalian receptors for interleukin-10 (IL-10) |
| AU3514997A (en) * | 1996-07-12 | 1998-02-09 | Schering Corporation | Mammalian tnf-alpha convertases |
| WO1999006548A2 (en) * | 1997-08-01 | 1999-02-11 | Genset | 5'ESTs FOR NON TISSUE SPECIFIC SECRETED PROTEINS |
| DK1887014T3 (da) * | 1997-10-17 | 2010-08-02 | Genentech Inc | Humane Toll-homologer |
-
1998
- 1998-05-07 CN CNA2008102136180A patent/CN101486759A/zh active Pending
- 1998-05-07 NZ NZ338073A patent/NZ338073A/en unknown
- 1998-05-07 DK DK98918934T patent/DK0980429T3/da active
- 1998-05-07 IL IL13261498A patent/IL132614A0/xx unknown
- 1998-05-07 CN CNB988066408A patent/CN1225555C/zh not_active Expired - Fee Related
- 1998-05-07 DE DE69841514T patent/DE69841514D1/de not_active Expired - Lifetime
- 1998-05-07 DE DE69836630T patent/DE69836630T2/de not_active Revoked
- 1998-05-07 JP JP54829998A patent/JP2002514083A/ja not_active Withdrawn
- 1998-05-07 AT AT98918934T patent/ATE348157T1/de not_active IP Right Cessation
- 1998-05-07 DE DE69841170T patent/DE69841170D1/de not_active Expired - Lifetime
- 1998-05-07 ES ES98918934T patent/ES2279572T3/es not_active Expired - Lifetime
- 1998-05-07 CN CNA2005100927155A patent/CN1800214A/zh active Pending
- 1998-05-07 KR KR10-1999-7010275A patent/KR100388860B1/ko not_active IP Right Cessation
- 1998-05-07 EP EP06025414A patent/EP1798288B1/en not_active Expired - Lifetime
- 1998-05-07 ES ES06025414T patent/ES2331622T3/es not_active Expired - Lifetime
- 1998-05-07 AU AU71754/98A patent/AU740333B2/en not_active Ceased
- 1998-05-07 AT AT06025414T patent/ATE443139T1/de active
- 1998-05-07 SK SK1465-99A patent/SK146599A3/sk unknown
- 1998-05-07 CN CNA2006101002207A patent/CN1935840A/zh active Pending
- 1998-05-07 DK DK06025414T patent/DK1798288T3/da active
- 1998-05-07 EP EP08104511A patent/EP1988166A1/en not_active Ceased
- 1998-05-07 AT AT07123073T patent/ATE458053T1/de not_active IP Right Cessation
- 1998-05-07 ES ES07123073T patent/ES2340210T3/es not_active Expired - Lifetime
- 1998-05-07 EP EP98918934A patent/EP0980429B1/en not_active Revoked
- 1998-05-07 PT PT06025414T patent/PT1798288E/pt unknown
- 1998-05-07 WO PCT/US1998/008979 patent/WO1998050547A2/en active IP Right Grant
- 1998-05-07 EP EP07123073A patent/EP1925666B1/en not_active Expired - Lifetime
- 1998-05-07 PL PL98336635A patent/PL336635A1/xx unknown
- 1998-05-07 CA CA2289912A patent/CA2289912C/en not_active Expired - Fee Related
- 1998-07-05 ID IDW991326A patent/ID28299A/id unknown
-
1999
- 1999-11-08 NO NO995458A patent/NO995458L/no not_active Application Discontinuation
-
2000
- 2000-02-25 HK HK00101136A patent/HK1022175A1/xx not_active IP Right Cessation
-
2004
- 2004-12-15 JP JP2004363734A patent/JP2005120106A/ja not_active Withdrawn
-
2005
- 2005-10-21 JP JP2005307907A patent/JP2006052232A/ja active Pending
-
2007
- 2007-10-11 HK HK08106460.0A patent/HK1112018A1/xx not_active IP Right Cessation
- 2007-10-11 HK HK07111049.1A patent/HK1102720A1/xx not_active IP Right Cessation
-
2008
- 2008-12-22 JP JP2008326610A patent/JP2009089713A/ja not_active Withdrawn
-
2009
- 2009-11-25 CY CY20091101218T patent/CY1109645T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005120106A5 (ja) | ||
| JP2012095652A5 (ja) | ||
| JP2007535912A5 (ja) | ||
| JP2007197439A5 (ja) | ||
| JP2015212284A5 (ja) | ||
| JP2006516189A5 (ja) | ||
| JP2009268467A5 (ja) | ||
| JP2009511000A5 (ja) | ||
| CA2636075A1 (en) | Chimaeric fusion protein with superior chaperone and folding activities | |
| JP2010529860A5 (ja) | ||
| JP2012152218A5 (ja) | ||
| JP2016505251A5 (ja) | ||
| JP2004532033A5 (ja) | ||
| RU2006127314A (ru) | Вакцина, стимулирующая рост, основанная на нейтрализующем эпитопе | |
| EA200870176A1 (ru) | НОВЫЙ ПОВЕРХНОСТНЫЙ БЕЛОК HAEMOPHILUS INFLUENZAE (БЕЛОК E; pE) | |
| JP2017512063A5 (ja) | ||
| JP2007513634A5 (ja) | ||
| JP2013517783A5 (ja) | ||
| JP2017509335A5 (ja) | ||
| JP2014503198A5 (ja) | ||
| MX340772B (es) | Medios y metodos para fabricar neurotoxina altamente pura. | |
| JP2008545393A5 (ja) | ||
| JP2016537981A5 (ja) | ||
| JP2014525439A5 (ja) | ||
| WO2010007144A3 (en) | Mutated netrin-4 proteins, fragments thereof and their uses as drugs |